Tyrosinemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2023-06-14
EMA Withdrawn: Nitisinone MDK (previously Nitisinone MendeliKABS) (nitisinone) — MendeliKABS Europe Ltd
EMA withdrawal of nitisinone MDK (nitisinone) from MendeliKABS Europe Ltd for tyrosinemias.